NASDAQ:BBH VanEck Biotech ETF (BBH) Price, Holdings, & News $155.44 -2.48 (-1.57%) Closing price 07/18/2025 03:54 PM EasternExtended Trading$155.46 +0.02 (+0.01%) As of 07/18/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock About VanEck Biotech ETF (NASDAQ:BBH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get VanEck Biotech ETF alerts:Sign Up Key Stats Today's Range$155.32▼$158.0950-Day Range$140.24▼$161.1452-Week Range$135.34▼$183.64Volume2,984 shsAverage Volume9,226 shsMarket Capitalization$334.20 millionAssets Under Management$339.01 millionDividend Yield0.80%Net Expense Ratio0.35%Aggregate RatingModerate Buy ETF Overview The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry. Read More VanEck Biotech ETF ExpensesTypeBBHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.35%0.56%0.56%0.54%0.53%Other Expenses0.00%0.47%0.56%0.52%0.56%Total Expense0.35%0.75%0.76%0.73%0.73%Fee Waiver0.00%-0.67%-0.66%-0.50%-0.63%Net Expense0.35%0.60%0.63%0.63%0.60% Receive BBH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VanEck Biotech ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address BBH ETF News HeadlinesVanEck Biotech ETF Dividends | NASDAQ:BBH | BenzingaMay 29, 2025 | benzinga.comBBH: Fear Of Price Controls Is Not The ProblemMay 14, 2025 | seekingalpha.comAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this marks the beginning of “Trump’s Great Gain,” a new crypto bull phase driven by emerging federal policies. He believes certain altcoins could turn $900 into $108,000 — and reveals everything in a new presentation. | Paradigm Press (Ad)Are Wall Street Analysts Predicting Vertex Pharmaceuticals Stock Will Climb or Sink?February 20, 2025 | msn.comVanEck Biotech ETF declares annual distribution of $1.2517December 27, 2024 | msn.comAre Rate Cuts Bad News For BIZD ETF?September 10, 2024 | seekingalpha.comSee More Headlines BBH ETF - Frequently Asked Questions How have BBH shares performed this year? VanEck Biotech ETF's stock was trading at $156.97 on January 1st, 2025. Since then, BBH stock has decreased by 1.0% and is now trading at $155.44. Who are VanEck Biotech ETF's major shareholders? Top institutional investors of VanEck Biotech ETF include EWG Elevate Inc. (0.11%). How do I buy shares of VanEck Biotech ETF? Shares of BBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of VanEck Biotech ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that VanEck Biotech ETF investors own include Meta Platforms (META), Micron Technology (MU), Advanced Micro Devices (AMD), Intel (INTC), NVIDIA (NVDA), Adobe (ADBE) and Johnson & Johnson (JNJ). Fund Details IssuerVan Eck Fund NameVanEck Biotech ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:BBH Inception Date12/20/2011 Fund ManagerHao-Hung Peter Liao, Guo Hua Jason Jin WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkMVIS US Listed Biotech 25 Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionGlobal Number of Holdings25 Fund Statistics Assets Under Management$339.01 million Average Daily Volume$7.44 thousand Discount/Premium-0.01% Administrator, Advisor and Custodian AdministratorVan Eck Associates Corporation AdvisorVan Eck Associates Corporation CustodianState Street Bank and Trust Company DistributorVan Eck Securities Corporation Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume4 Put Options2 Call Options4 Short Interest3,800 shs Miscellaneous Outstanding Shares2,150,000Beta0.72 Creation Unit50,000 Creation Fee$500.00 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Top 10 BBH HoldingsAmgen (NASDAQ:AMGN)Holding Weight: 15.81%Gilead Sciences (NASDAQ:GILD)Holding Weight: 12.99%Vertex Pharmaceuticals (NASDAQ:VRTX)Holding Weight: 10.58%Regeneron Pharmaceuticals (NASDAQ:REGN)Holding Weight: 5.09%argenex (NASDAQ:ARGX)Holding Weight: 4.93%Alnylam Pharmaceuticals (NASDAQ:ALNY)Holding Weight: 4.86%Natera (NASDAQ:NTRA)Holding Weight: 4.60%IQVIA (NYSE:IQV)Holding Weight: 4.54%Insmed (NASDAQ:INSM)Holding Weight: 3.70%Biogen (NASDAQ:BIIB)Holding Weight: 3.48%Full Holdings DetailsBBH Sector ExposureBBH Industry Exposure This page (NASDAQ:BBH) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
